Evidence map›Paper›PMID 36079814›Full record

ReviewNutrients2022

Exploring the Potential of Human Milk and Formula Milk on Infants' Gut and Health.

Hui-Yuan Chong, Loh Teng-Hern Tan, Jodi Woan-Fei Law, Kar-Wai Hong, Vanassa Ratnasingam, Nurul-Syakima Ab Mutalib, Learn-Han Lee, Vengadesh Letchumanan

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05815433 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants Exposed to Antibiotics in Labour: A Pilot Randomized Controlled Trial

TypeinterventionalSponsorUniversity of CalgaryRan2023 to 2025Enrolled105ConditionsMicrobial ColonizationArmsDonor Human Milk - Nutritional Replacement
NCT06177184 narecruitingnot on this mapstarted 2024, after this paper: background citation

DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Caesarean Section

TypeinterventionalSponsorUniversity of CalgaryRan2024 to 2027Enrolled90ConditionsMicrobial ColonizationArmsDonor Human Milk - Nutritional Replacement
3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. The Microbiota as a Potential Cause of Disease.Diseases (Basel, Switzerland) · 2026
    Review
  5. Review
  6. The Critical Period Microbiota Shape Brain Plasticity.bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Health benefits ofFrontiers in microbiology · 2026
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui-Yuan ChongNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0002-8416-7574
Loh Teng-Hern TanNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0003-1421-3130
Jodi Woan-Fei LawNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0003-2344-4571
Kar-Wai HongNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.
Vanassa RatnasingamClinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Johor Bahru 80100, Malaysia.
Nurul-Syakima Ab MutalibNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0001-6914-2224
Learn-Han LeeNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0002-8589-7456
Vengadesh LetchumananNovel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.ORCID 0000-0002-2145-6854

Funding

External Industry Grant from Biomerge Sdn Bhd BMRG2018-01Jeffrey Cheah School of Medicine and Health Sciences Early Career Researcher Grant 2021 ECR-000021Jeffrey Cheah School of Medicine and Health Sciences Strategic Grant 2022 STG-000108
6 · The paper itself

Abstract

Early-life gut microbiota plays a role in determining the health and risk of developing diseases in later life. Various perinatal factors have been shown to contribute to the development and establishment of infant gut microbiota. One of the important factors influencing the infant gut microbial colonization and composition is the mode of infant feeding. While infant formula milk has been designed to resemble human milk as much as possible, the gut microbiome of infants who receive formula milk differs from that of infants who are fed human milk. A diverse microbial population in human milk and the microbes seed the infant gut microbiome. Human milk contains nutritional components that promote infant growth and bioactive components, such as human milk oligosaccharides, lactoferrin, and immunoglobulins, which contribute to immunological development. In an attempt to encourage the formation of a healthy gut microbiome comparable to that of a breastfed infant, manufacturers often supplement infant formula with prebiotics or probiotics, which are known to have a bifidogenic effect and can modulate the immune system. This review aims to elucidate the roles of human milk and formula milk on infants' gut and health.

Indexed as

Gastrointestinal MicrobiomeMilk, HumanBreast FeedingFemaleHumansInfantInfant FormulaPrebioticsPrebioticsformula milkgut microbiotahuman milkimmune systeminfant

Identifiers

PMID36079814
PMCPMC9460722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.